Endothelin-induced nociception in mice: Mediation by ETA and ETB receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 647-651

  Raffa, Robert B ^a   Schupsky, James J ^a   Jacoby, Henry I ^a,b  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

^b Drug Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; PEPTIDE FRAGMENT; SARAFOTOXINS S6; VIPER VENOM;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MOUSE; PAIN; PHYSIOLOGY;

ANIMALS; ENDOTHELINS; MALE; MICE; MICE, INBRED ICR; PAIN; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; VIPER VENOMS;

EID: 0030087732     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. ADACHI, M., YANG, Y.-Y., TRZECIAK, A., FURUIOHI, Y. AND MIYAMOTO, C.: Identification of a domain of ETA receptor required for ligand binding. FEBS Lett 311: 179-183, 1992.
2. ASAI, H., HORI, S., ARAMORI, I., OHKUBO, H. AND NAKANISHI, S.: Cloning and expression of a cDNA encoding an endothelin receptor. Nature (Lond.) 348: 730-732, 1990.
3. BLOCH, K. D., EDDY, R. L., SHOWS, T. B. AND QUERTERMOUS, T.: cDNA cloning and chromosomal assignment of the gene encoding endothelin 3. J. Biol. Chem. 264: 18156-18161, 1989.
4. CHENG, X.-M., NIKAM, S. S. AND DOHERTY, A. M.: Development of agents to modulate the effects of endothelin. Curr. Med. Chem. 1: 271-312, 1994.
5. COLLIER, H. O. J., DINNEEN, L. C., JOHNSON, C. A. AND SCHNEIDER, C.: The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol. 32: 295-310, 1968.
6. DAHLOF, B., GUSTAFSSON, D., HEDNER, T., JERN, S. AND HANNSSON, L.: Regional hemodynamic effects of endothelin-1 in rat and man: Unexpected adverse effects. J. Hypertension 8: 811-818, 1990.
7. DOHERTY, A, M.: Endothelin: a new challenge. J. Med. Chem. 35: 1493-1508, 1992.
8. FERREIRA, S. H., ROMITELLI, M. AND DE NUCCI, G.: Endothelin-1 participation in overt and inflammatory pain. J. Cardiovasc. Pharmacol. 13:suppl 5, S220-S222, 1989.
9. GULATI, A. AND SRIMAL, R. C.: Endothelin mechanisms in the central nervous system: A target for drug development. Drug Develop. Res. 26: 361-387, 1992.
10. HICKEY, K. A., RUBANYI, G., PAUL, R. J. AND HIGHSMITH, R. F.: Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am. J. Physiol. 248: C550-C556, 1985.
11. HILLIS, L. D. AND BRAUNWALD, E.: Coronary-artery spasm. New Eng. J. Med. 299: 695-702, 1978.
12. A receptor. Life Sci. 50: 247-255, 1992.
13. IKEGAWA, R., MATSUMURA, Y., TSUKAHARA, Y., TAKAOKA, M. AND MORIMOTO, S.: Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem. Biophys. Res. Commun. 171: 669-675, 1990.
14. ITOH, Y., YANAGISAWA, M., OHKUBO, S., KIMURA, C., KOSAKA, T., INOUE, A., ISHIDA, N., MITSUI, Y., ONDA, H., FUJINA, M. AND MASAKI, T.: Cloning and squence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: Identity of human and procine endothelin. FEBS Lett. 231: 440-444, 1988.
15. KLOOG, Y. AND SOKOLOVSKY, M.: Similarities in mode and sites of action of sarafotoxins and endothelins. Trends Pharmacol Sci. 10: 212-214, 1989.
16. KRYSTEK, S. R. JR., PATEL, P. S., ROSE, P. M., FISHER, S M., KIENZLE, B. K., LACH, D. A., LIU, E. C.-K., LYNCH, J. S., NOVOTNY, J. AND WEBB, M. L.: Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. J. Biol. Chem. 269: 12383-12386, 1994.
17. KURIHARA, H., YOSHIZUMI, M., SUGIYAMA, T., YAMAOKI, K., NAGAI, R., TAKAKU, F., SATOH, H., INUI, J., YANAGISAWA, M., MASAKI, T., AND YAZAKI, Y.: The possible role of endothelin-1 in the pathogenesis of coronary vasospasm. J. Cardiovasc. Pharmacol. 13:suppl. 5, S132-S137, 1989.
18. MAGGI, C. A., GIULIANI, S., PATACCHINI, R., SANTICIOLI, P., ROVERO, P., GIACHETTI, A. AND MELI, A.: The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors Eur. J. Pharmacol. 166: 121-122, 1989.
19. MARIN, P , DELUMEAU, J. C., DURIEU-TRAUTMANN, O., LE NGUYEN, D., PRÉMONT, J., STROSBERG, A. D. AND COURAUD, P. O.: Are several G proteins involved in the different effects of endothelin-1 in mouse striatal astrocytes? J. Neurochem. 56: 1270-1275, 1991.
20. MASAKI, T., VANE, J. R. AND VANHOUTTE, P. M.: V. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol. Rev. 46: 137-142, 1994.
21. MASERI, A., L'ABBATE, A., CHIERCHIA, S., PARODI, O., SEVERI, S., BIAGINI, A., DISTANTE, A., MARZILLI, M, AND BALLESTRA, A. M.: Significaace of spasm in the pathogeneeis of ischemic heart disease. Am. J. Cardiol. 44: 788-792, 1979.
22. MATSAS, R., KENNY, A. J. AND TURNER, A. J.: The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins and their analogues, by endopeptidase 24.11. Biochem. J. 223: 433-440, 1984.
23. MCMAHON, E. G., PALOMO, M. A., MOORE, W. M., MCDONALD, J. F. AND STERN, M. K.: Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc. Nat. Acad. Sci U.S.A. 88: 703-707, 1991.
24. MIURA, K., KUROSE, I., FUKUMURA, D., SUEMATSU, M., SEKIZUKA, E., TASHIRO, H., SERIZAWA, H., ASAKO, H. AND TSUCHIYA, M.: Ischemic bowel necrosis induced by endothelin-1: An experimental model in rats. Digestion 48: 163-172, 1991.
25. OKADA, K., MIYAZAKI, Y., TAKADA, J., MATSUYAMA, K., YAMAKI, T. AND YAND, M.: Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem. Biophys. Res. Commun. 171: 1192-1198, 1990.
26. ONDETTI, M. A., RUBIN, B. AND CUSHMAN, D. W.: Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science (Wash DC) 196: 441-444, 1977.
27. ORNING, L., KRIVI, G. AND FITZPATRICK, F. A.: Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes. J. Biol. Chem. 266: 1375-1378, 1991.
28. PEROUTKA, S. J.: Endothelin receptors. In Handbook of Receptors and Channels, ed. by S. J. Peroutka, pp. 125-128, CRC Press, Boca Raton, FL, 1994.
29. RAFFA, R. B. AND JACOBY, H. I.: Endothelin-1, -2 and -3 directly and bigendothelin-1 indirectly elicit an abdominal constriction response in mice. Life Sci./Pharmacol. Lett. 48: PL85-PL90, 1991
30. RAFFA, R. B., SCHUPSKY, J. J., MARTINEZ, R. P. AND JACOBY, H. I.: Endothelin-1-induced nociception. Life Sci./Pharmacol. Lett. 49: PL61-PL65, 1991.
31. ROQUES, B. P., FOURNIÉ-ZALUSKI, M. C., SOROCA, E., LECOMTE, J. M., MALFROY, B., LLORENS, C. AND SCHWAKTZ, J.-C.: The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature (Lond.) 288: 286-288, 1980.
32. RUBANYI, G. M.; Potential physiological and pathological significance of endothelins. Drugs of the Future 17: 915-936, 1992.
33. B-selective agonists. J. Biol. Chem. 268: 8547-8553, 1993.
34. SAKURAI, T., YANAGISAWA, M., TAKUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. AND MASAKI, T : Cloning of a cDNA encoding a non-isopeptide-seleetive subtype of the endothelin receptor. Nature (Lond.) 348: 732-735, 1990.
35. SAWAMURA, T., KASUYA, Y., MATSUSHITA, Y., SUZUKI, N., SHINMI, O., KISHI, N., SUGITA, Y., YANAGISAWA, M., GOTO, K., MASAKI, T., AND KIMURA, S.: Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells. Biochem. Biophys. Res. Comm. 174: 779-784, 1991.
36. B receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol. 107: 858-860, 1992.
37. TALLARIDA, R. J. AND MURRAY, R. B.: Manual of Pharmacologic Calculations with Computer Programs, 2nd ed., pp. 35-44, Springer-Verlag, New York, 1987.
38. TAYLOR, A.: Aminopeptidases: Structure and function. FASEB J. 7: 290-298, 1993.
39. TODD, P. A. AND FITTON, A.: Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders Drugs 42: 90-114, 1991.
40. YANAGISAWA, M. AND MASAKI, T.: Molecular biology and biochemistry of the endothelins. Trends Pharmacol. Sci. 10: 374-378, 1989.
41. YANAGISAWA, M., KURIIIARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. AND MASAKI, T.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.) 332:411-415, 1988.